B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ID4

MOLECULAR TARGET

inhibitor of DNA binding 4

UniProt: P47928NCBI Gene: 34003 compounds

ID4 (inhibitor of DNA binding 4) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ID4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alpha-Linolenic Acid0.691
2Dehydrocholic Acid0.691
3Practolol0.691

About ID4 as a Drug Target

ID4 (inhibitor of DNA binding 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented ID4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ID4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.